Conivaptan Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Conivaptan Hydrochloride Injection (injection) from Cumberland Pharmaceuticals Inc. with status Current. The shortage was first posted on Mar 14, 2022. Reported reason: Delay in shipping of the drug
Shortage details
- Status
- Current
- Company
- Cumberland Pharmaceuticals Inc.
- Package NDC
- 66220-160-10
- Dosage Form
- Injection
- Presentation
- Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)
- Initial Posting
- Mar 14, 2022
Reason
Delay in shipping of the drug